EyewireTV — Zepto Approved in US; B+L Surgical Products for Sale?
In this week’s EyewireTV, Mynosys Cellular Devices receives FDA 510(k) clearance for the Zepto Capsulotomy System; and the FDA approves Nicox’s allergic conjunctivitis drug Zerviate (cetirizine 0.24%), the first topical ocular formulation of the antihistamine cetirizine. Also, Valeant reportedly is in talks to sell its Bausch + Lomb unit’s surgical products business to Carl Zeiss Meditec.

View Video Here